EE307 Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis for Social Security and Private Third-Party Payers in Argentina
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.608
https://www.valueinhealthjournal.com/article/S1098-3015(23)00708-8/fulltext
Title :
EE307 Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis for Social Security and Private Third-Party Payers in Argentina
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00708-8&doi=10.1016/j.jval.2023.03.608
First page :
Section Title :
Open access? :
No
Section Order :
10091